Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion
Status:
Recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to compare breast symptoms (lactation, engorgement, etc)
of individuals who undergo a procedure for second trimester of pregnancy loss between 16
weeks and 20 weeks gestational age. The participants will be randomly placed in two groups,
one with a placebo tablet and one with medication called "cabergoline" which are taken
immediately after their procedure. Researchers will compare groups to see if there are any
significant differences in breast symptoms.